AQR Capital Management’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

AQR Capital Management’s Portfolio PTX Stock Details PTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-143,960	Closed	-$645K	–	2334
2016 Q2	$645K	Buy	143,960 +42,649	+42%	+$278K	﹤0.01%	1779
2016 Q1	$1.06M	Buy	101,311 +10,091	+11%	+$201K	﹤0.01%	1556
2015 Q4	$2.69M	Buy	91,220 +47,973	+111%	+$1.45M	﹤0.01%	1117
2015 Q3	$1.37M	Buy	43,247 +21,468	+99%	+$1.03M	﹤0.01%	1288
2015 Q2	$1.29M	Buy	21,779 +10,193	+88%	+$719K	﹤0.01%	1381
2015 Q1	$1.24M	Sell	11,586 -14,920	-56%	-$1.42M	﹤0.01%	1321
2014 Q4	$2.49M	Sell	26,506 -534	-2%	-$50.9K	0.01%	1188
2014 Q3	$2.08M	Buy	27,040 +24,570	+995%	+$1.93M	0.01%	1245
2014 Q2	$222K	Buy	+2,470	New	+$151K	﹤0.01%	2330

Other funds holding PTX

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Globeflex Capital San Diego, California $661M AUM 50.59% 1-Year Est. Return

Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

AQR Capital Management's PTX Position: Q3 2016 in Review

AQR Capital Management sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q3 2016, closing a stake of 143,960 shares — an estimated $645K sold.

AQR Capital Management first reported a position in PTX in Q2 2014 and held it in 9 quarters. The position peaked at $2.69M in Q4 2015. 48 funds tracked by Wall St. Rank hold PTX as of Q3 2016.

AQR Capital Management reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q3 2016 after selling out during the quarter.
AQR Capital Management sold 143,960 Pernix Therapeutics Holdings, Inc. shares in Q3 2016, an estimated $645K.
AQR Capital Management first reported a position in Pernix Therapeutics Holdings, Inc. in Q2 2014 and held it in 9 quarters.
AQR Capital Management's Pernix Therapeutics Holdings, Inc. position peaked at $2.69M in Q4 2015.
48 funds tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q3 2016.

Based on AQR Capital Management's 13F filing for Q3 2016, filed 14 Nov 2016.